Houston scores respectable rank in new report of best U.S. cities for working-class families

is the living easy?

Houstonians live well. Photo via Getty Images

A new economic analysis by the Ludwig Institute for Shared Economic Prosperity (LISEP) has revealed that Houston-The-Woodlands-Sugar Land has the 30th most prosperous local economy in the nation. The analysis ranked the 50 largest Metropolitan Statistical Areas (MSAs) in the U.S. based on several localized economic factors.

According to Houston's data, the region's population has skyrocketed 18.7 percent within the last decade, now reaching over 7.34 million people. The median age of an Houston-area resident is 35.1-years-old.

The three main criteria that determined Houston's prospering rank include a "True Living Cost" metric that tracks price changes for essential household necessities; a "True Weekly Earnings" calculation that determines the median weekly earnings of all workers (including part-timers and those who are unemployed); and a "True Rate of Unemployment Out of the Population" metric that measures the percentage of people unable to find full-time employment with a living wage.

The findings show that a little more than half of all Houston-area households are earning enough income to afford their basic needs. The remaining 46.4 percent are struggling due to a high cost of living, the report said.

"The total costs of necessities for a 4-person family [in Houston-The Woodlands-Sugar Land] increased 58.2 percent since 2005 from $54,052 to $85,492," the report said.

Furthermore, Houstonians are bringing home higher weekly earnings than they were in 2020. Houston workers are earning a median $894.89 per week, or about $47,429.17 a year. The report states the average employee has gained 8.2 percent more purchasing power since 2005, and the average Houston household has 8.1 percent of their income leftover after their necessities.

Houston's "True Rate of Unemployment Out of the Population" is 63 percent, according to the analysis.

The objective behind LISEP's report is to help policymakers assess their local economies' dynamics and to assess how much low-income and working-class families are affected, according to LISEP Chairman Gene Ludwig in the release.

"Across the nation we are seeing both ends of the spectrum — communities where middle- and working-class families are faring well and others where financial survival remains a struggle," Ludwig said. "Our challenge here is in identifying what's working well and replicating it; what's not, and scrapping it. This is where real-world data can be invaluable to policymakers."

Houston-The Woodlands-Sugar Land wasn't the only Texas metro area to earn a spot in the analysis. Austin-Round Rock worked its way up into No. 2 nationally, while San Antonio-New Braunfels ranked just outside the top 10 at No. 13. Dallas-Fort Worth-Arlington ranked four spots higher than Houston at No. 26.

The top 10 highest-performing economies in the U.S. are:

  • No. 1 – San Jose-Sunnyvale, Santa Clara, California
  • No. 2 – Austin-Round Rock, Texas
  • No. 3 – San Francisco-Oakland-Hayward, California
  • No. 4 – Baltimroe-Columbia-Towson, Maryland
  • No. 5 – Washington-Arlington-Alexandria, District of Columbia-Virginia-Maryland
  • No. 6 – Minneapolis-St. Paul-Blookington, Minnesota-Wisconsin
  • No. 7 – Portland-Vancouver-Hillsboro, Oregon-Washington
  • No. 8 – Milwaukee-Waukesha-West Allis, Wisconsin
  • No. 9 – Denver-Aurora-Lakewood, Colorado
  • No. 10 – Salt Lake City, Utah
The full report and its methodology can be found on lisep.org.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston medtech firm secures $30M for neurosurgical robot

stroke surgery

Robotic neurosurgery is an exciting new frontier in medicine, and Houston-based medtech firm XCath is leading the charge with its revolutionary Iris robotic system. The company announced in March that it had secured $30 million in Series C funding to continue developing systems to tackle blood clots in the human brain.

“We are grateful to our investors for their conviction in our shared mission to improve clinical outcomes for patients impacted by endovascular diseases,” Eduardo Fonseca, CEO of XCath, said in a news release. “In 2025, the XCath team advanced the frontiers of endovascular robotics. This funding accelerates our commitment to expanding access to life-saving care so that where a patient lives no longer determines whether they live.”

XCath–which also has campuses in Pangyo, South Korea–has already achieved a number of remarkable firsts in robotic neurosurgery. The Iris is the only endovascular robotic system currently in development to perform intracranial navigation or neurointerventional treatment, and is the only robot in the world to have performed an intracranial neurovascular procedure involving the robotic manipulation of three devices.

These new Series C funds, which bring the company's total investment to $92 million, will go toward developing a clinical telerobot capable of performing a mechanical thrombectomy. This would bring unprecedented accuracy and precision to the surgical removal of brain clots, significantly reducing the risk of neurosurgery.

“Robotic surgery succeeds when innovation is paired with practical execution,” Dr. Fred Moll, chairman of the XCath board of directors, said in the release. “XCath has built a promising technology foundation, and just as importantly, a team that values rigor and appreciates perspective. I’m excited to support them as they take on the mission of globalizing access to gold-standard care for stroke patients.”

In November 2025, the Iris debuted under the control of Dr. Vitor Mendes Pereira at The Panama Clinic in Panama City, alongside local Principal Investigator Dr. Anastasio Ameijeiras Sibauste. It was only the second time in human history that a robot had been used for intracranial neurovascular intervention, and it established Iris as a viable technology in the fight against stroke.

“Treatment of stroke and other neurovascular diseases represents one of the most significant financial opportunities in healthcare, supported by positive reimbursement dynamics and strong demand from health systems,” Nicholas Drysdale, CFO of XCath, added in the release. “With our continued investor support and disciplined capital deployment, XCath is positioned to build a category-leading platform in endovascular robotics”.

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

View All Listings